Nutritional Management of Polycystic Ovarian Disease: Integrating Unani and Contemporary Approaches

Year : 2025 | Volume : 12 | Issue : 02 | Page : 1 6
    By

    Sadaf Naaz,

  • Mahfooz ur Rehman,

  • Hina Khan,

  • Saliha,

  1. PG Scholar, H.S.Z.H Unani Medical College, Bhopal, Madhya Pradesh,
  2. H.O.D, H.S.Z.H Unani Medical College, Bhopal, Madhya Pradesh, India
  3. PG Scholar, H.S.Z.H Unani Medical College, Bhopal, Madhya Pradesh, India
  4. PG Scholar, H.S.Z.H Unani Medical College, Bhopal, Madhya Pradesh, India

Abstract

In Unani medicine, dietary management, known as Ilaj bil Ghiza, plays a vital role in restoring humoral balance and maintaining a healthy temperament (mizaj). This principle aligns with modern medical understanding, particularly in conditions, like polycystic ovarian syndrome (PCOS), which is often associated with insulin resistance and obesity. Modifying dietary habits has shown promise in improving both metabolic and reproductive functions in PCOS patients. Unani scholars attribute PCOS to a Sue Mizaj Barid Ratab (cold and moist temperament), advising consumption of foods with hot and dry qualities. Modern perspectives support the intake of low-glycemic foods while avoiding high-glycemic ones. This review explores the dietary recommendations for managing PCOS through the lens of both Unani and contemporary medical systems.

Keywords: Polycystic ovarian syndrome, Unani concept, diet, lifestyle, temperament

[This article belongs to Research & Reviews : A Journal of Unani, Siddha and Homeopathy ]

How to cite this article:
Sadaf Naaz, Mahfooz ur Rehman, Hina Khan, Saliha. Nutritional Management of Polycystic Ovarian Disease: Integrating Unani and Contemporary Approaches. Research & Reviews : A Journal of Unani, Siddha and Homeopathy. 2025; 12(02):1-6.
How to cite this URL:
Sadaf Naaz, Mahfooz ur Rehman, Hina Khan, Saliha. Nutritional Management of Polycystic Ovarian Disease: Integrating Unani and Contemporary Approaches. Research & Reviews : A Journal of Unani, Siddha and Homeopathy. 2025; 12(02):1-6. Available from: https://journals.stmjournals.com/rrjoush/article=2025/view=209256


References

  1. Lim SS, Hutchison SK, Van Ryswyk E, Norman RJ, Teede HJ, Moran LJ. Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database Syst Rev. 2019;2019:CD007506.
  2. Nidhi R, Padmalatha V, Nagarathna R, Amritanshu R. Prevalence of polycystic ovarian syndrome in Indian adolescents. J Pediatr Adolesc Gynecol. 2011;24:223–7.
  3. Franks S. Polycystic ovary syndrome. N Engl J Med. 1995;333:853–61.
  4. Ratna Kumari ME, Manavalan N, Sathya Nath D, Ayda YR, Reka K. Study to evaluate the changes in polycystic ovarian morphology after naturopathic and yogic interventions. Int J Yoga. 2018;11:139–47.
  5. Goodman NF, Cobin RH, Futterweit W, Glueck JS, Legro RS, Carmina E, et al. American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society disease state clinical review: Guide to the best practices in the evaluation and treatment of polycystic ovary syndrome Part 2. Endocr Pract. 2015;21:1415–26.
  6. Salari N, Nankali A, Ghanbari A, et al. Global prevalence of polycystic ovary syndrome in women worldwide: a comprehensive systematic review and meta-analysis. Arch Gynecol Obstet. 2024. https://doi.org/10.1007/s00404-024-07607-x
  7. Ganie MA, Vasudevan V, Wani IA, Baba MS, Arif T, Rashid A. Epidemiology, pathogenesis, genetics & management of polycystic ovary syndrome in India. Indian J Med Res. 2019;150(4):333–44.
  8. Barberi RL. Induction of ovulation in infertile women hyperandrogenism and insulin resistance. Am J Obstet Gynecol. 2000;183:1412–8.
  9. Mac Pannill. Polycystic Ovary Syndrome: An Overview. Top Adv Pract Nurs eJ. 2002;2(3).
  10. Poretsky L, Piper B. Insulin resistance, hypersensitivity of LH, and dual defect hypothesis for the pathogenesis of polycystic ovary syndrome. Obstet Gynecol. 1994;84:613–21.
  11. Barberi RL, Ryan KJ. Hyperandrogenism, insulin resistance, and acanthosis nigricans syndrome: a common endocrinopathy with distinct pathophysiologic features. Am J Obstet Gynecol. 1983;147:90–101.
  12. Barberi RL. Some genetic syndromes associated with hyperandrogenism. Contemp Obstet Gynecol. 1994;39:35–48.
  13. Kidson W. Polycystic ovary syndrome: a new direction in treatment. Med J Aust. 1998;169:537–40. Available from: http://www.mja.com.au/public/issues/nov16/kidson/kidson.html
  14. Lobo RA, Camina E. The importance of diagnosing the polycystic ovary syndrome. Ann Intern Med. 2000;132:989–93. Available from: http://www.geocities.ws/mim_subspec/AnnIntMed-PCOS.pdf
  15. Razi ABZ. Al Hawi-Fil-Tib. Vol IX. New Delhi: CCRUM; 2001. p. 151–68.
  16. Bhat SA, et al. Clinical Study of Polycystic Ovarian Syndrome with a Unani Formulation: A Randomized Single-Blind Placebo Controlled Study. Am J Pharm Health Res. 2015.
  17. Ibn-e-Hubal Baghdadi. Kitab-al-Mukhtarat Fil Tibb. Vol II & IV. New Delhi: CCRUM; 2007. Vol II p. 50–51, 57–58, 74–75, 77–78, 100–101, 112–113, 213–215; Vol IV p. 31–35.
  18. Majoosi ABA. Kamil-us-Sanaa (Urdu translation by Kantoori GH). Lucknow: Munshi Nawal Kishore; 1889. p. 110–12, 486–88.
  19. Mohammed Tabri. Moalijat e Buqratiya (Urdu). Part 3. New Delhi: CCRUM; p. 215–16.
  20. Ibn Sina. Al Qanoon Fil Tib (Urdu translation by Kantoori GH). New Delhi: Idara Kitab-us-Shifa; 2010. p. 280, 328, 1088–89, 1095–98.
  21. Jurjani I. Zakheerae Khawarzam Shahi (Urdu trans. by Khan AH). Vol VI. New Delhi: Idara Kitab-us-Shifa; 2010 Jan. p. 597–602.
  22. Qumri AMH. Ghina Muna. 1st ed. New Delhi: CCRUM; 2008. p. 410–13, 435–37.
  23. Khan A. Al Akseer (Urdu translation by Kabeeruddin). New Delhi: Idara Kitab-us-Shifa; 2011 Jan. p. 797–801.
  24. Deshpande S, et al. Effect of Polyherbal Formulation in Treatment of Polycystic Ovarian Syndrome (PCOS). IOSR J Pharm Biol Sci. 2013;5(5):63–6.
  25. Wang HS, Wang TH. Polycystic ovary syndrome (PCOS), insulin resistance and insulin-like growth factors (IGFs)/IGF binding proteins (IGFBPs). Chang Gung Med J. 2003;26:540–53.
  26. Ortega-Gonzalez C, Luna S, Hernandez L, Crespo G, Aguayo P, Arteaga-Troncoso G, et al. Responses of serum androgen and insulin resistance to metformin and pioglitazone in obese, insulin-resistant women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2005;90:1360–5.
  27. S. Department of Health and Human Services, Office of Women’s Health. Polycystic ovary syndrome (PCOS) fact sheet [Internet]. 2010 [cited 2012 Apr 24]. Available from: http://www.womenshealth.gov/publications/our-publications/factsheet/polycystic-ovary-syndrome.html
  28. Barbieri RL. Ferriman-Gallwey scoring system for hirsutism. In: Dale DC, Federman DD, editors. Polycystic Ovary Syndrome. Women’s Health. WebMD Scientific American® Medicine Online. New York: WebMD Corporation; 2002. Available from: http://www.samed.com
  29. Slowey MJ. Polycystic ovary syndrome: new perspective on an old problem. South Med J. 2001;94:190–6.
  30. Dokras A, Clifton S, Futterweit W, Wild R. Quality of life issues and PCOS. Fertil Steril. 2012;97:225–30.
  31. Hameed L, Farooq AD, Qureshi T, Mohiuddin E. Dietary management of Takayus al Mebyadh (polycystic ovarian syndrome). Hamdard Medicus. 2017;6(1):67–81.
Regular Issue Subscription Review Article
Volume 12
Issue 02
Received 26/04/2025
Accepted 29/04/2025
Published 30/04/2025
Publication Time 4 Days
250

Login


My IP

PlumX Metrics